Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

What is the Skeletal System?

What is the Skeletal System?

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dynamics of slow wave sleep in advanced Parkinson's disease: An entropy-based study.

Neurobiology of disease·2026

Same author

Altered wakeful theta activity characterizes levodopa-induced dyskinesia in Parkinson's disease.

NPJ Parkinson's disease·2026

Same author

Precision Neuromodulation Treatment Reverses Motor and Cognitive Slowing After Stroke: Clinical and Neurophysiological Evidence.

Journal of clinical medicine·2026

Same author

JNK3 quantification in plasma: a novel biomarker for neuronal damage in Parkinson's disease.

NPJ Parkinson's disease·2025

Same author

Enhancing Social Cognition in Mild Cognitive Impairment with Non-Invasive Brain Stimulation: A Randomized Clinical Trial.

Neurorehabilitation and neural repair·2025

Same author

Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).

PLoS medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Parkinson's disease and the bones.

Markus Gnädinger¹, Hans-Ulrich Mellinghoff, Alain Kaelin-Lang

¹Facharzt für Innere Medizin, Birkenweg 8, 9323 Steinach, CH. markus.gnaedinger@hin.ch

Swiss Medical Weekly

|February 18, 2011

Summary

This summary is machine-generated.

Parkinson's disease (PD) patients face higher fracture risks due to falls and low bone density. Early evaluation for fall risk and osteoporosis, plus vitamin D supplementation, is recommended for all new PD diagnoses.

More Related Videos

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Related Experiment Videos

Last Updated: Jun 4, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Area of Science:

Neurology
Orthopedics
Geriatrics

Background:

Parkinson's disease (PD) is associated with musculoskeletal issues like decreased mobility, poor posture, and falls.
Postural instability and falls are common in PD patients, leading to acute and chronic musculoskeletal damage.

Purpose of the Study:

To review existing literature on bone health and fracture risk in patients with Parkinson's disease.

Main Methods:

A comprehensive literature review was conducted focusing on bone health in Parkinson's disease patients.

Main Results:

PD patients exhibit an increased risk of fractures, particularly hip fractures, linked to a higher incidence of falls.
Factors predicting falls include rigidity, bradykinesia, and postural instability. Fractures also correlate with reduced bone mineral density, characteristic of high-turnover osteoporosis in PD.
PD patients generally present with lower bone mineral density compared to age- and sex-matched controls.

Conclusions:

Newly diagnosed PD patients require assessment for fall risk and osteoporosis, with routine vitamin D supplementation.
Osteoporosis management in PD includes blood tests for underlying causes and bisphosphonate treatment.
Further research is needed on the impact of PD medications on bone metabolism, with regulatory bodies urged to require safety data.